ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation

Xu, Yipeng; Pachnikova, Gabriela; Wang, He; Wu, Yaoyao; Przybilla, Dorothea; Schaefer, Reinhold; Chen, Zihao; Zhu, Shaoxing*; Keilholz, Ulrich*南方医科大学; 中国科学院研究生院; 中国科学院; 1
Bosnian Journal of Basic Medical Sciences2022DOI: 10.17305/bjbms.2022.7279
4被引6阅读
引用收藏
分享

摘要

Preclinical models of tumors have the potential to become valuable tools for commercial drug research and development, and 3D culture systems are gaining traction in this area, particularly in prostate cancer (PCa) research. However, nearly all 3D drug design and screening assessments are based on 2D experiments, suggesting limitations of 3D drug testing. To simulate the natural response of human cells to the drug, we detected the half-maximal inhibitory concentration (IC50) changes of 2D/3D LNCaP cells in the drug docetaxel, as well as the sensitivity of different morphologies of 2D/3D LNCaP to docetaxel treatment. In contrast to 2D LNCaP cells, the evaluation of LNCaP spheroids' susceptibility to treatment was more complicated; the fitness of IC50, curves of 2D and 3D tumor cell preclinical models differs significantly. IC50 curves were unsuitable for large-sized LNCaP spheroids. More evaluation indexes (such as max inhibition) and experiments (such as spheroids formation) should be explored and performed to evaluate the susceptibility systematically.

学科与关键词

关键词
IC50docetaxelspheroidsdrug testingpreclinical modelsprostate cancer2D clinical models3D clinical modelscell culture
相关
加载中…
  • Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D-and 3D-Culture Systems
    Xu, Yipeng; Pachnikova, Gabriela; Przybilla, Dorothea; Schafer, Reinhold; Cui, Yingying; Zhou, Dan; Chen, Zihao; Zhao, An*; Keilholz, Ulrich*Frontiers in Pharmacology, 2022, 13: 839620.被引 6
  • Three-dimensional cell culture: the missing link in drug discovery
    Breslin, Susan; O'Driscoll, Lorraine*Drug Discovery Today, 2013, 18(5-6): 240-249.被引 927
  • The multicellular tumor spheroid model for high-throughput cancer drug discovery
    LaBarbera, Daniel V.*; Reid, Brian G.; Yoo, Byong HoonExpert Opinion on Drug Discovery, 2012, 7(9): 819-830.被引 198
查看全部 →

发表信息

论文状态
公开发表
期刊
Bosnian Journal of Basic Medical Sciences
发表日期
2022
卷期
第 22 卷, 第 4 期
页码
580-592
DOI
10.17305/bjbms.2022.7279
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Natural Science Foundation of Zhejiang Province [LQ20H160007]; ZAST International Medical Cooperation Programme

作者

  • X

    Xu, Yipeng (第一作者)

    chinese acad sci · univ chinese acad sci · zhejiang canc hosp

  • P

    Pachnikova, Gabriela

查看全部 9 位作者收起作者
  • W

    Wang, He

  • W

    Wu, Yaoyao

    2 · zhejiang chinese med univ

  • P

    Przybilla, Dorothea

  • S

    Schaefer, Reinhold

  • C

    Chen, Zihao

    southern med univ

  • Z

    Zhu, Shaoxing (通讯)

    univ chinese acad sci · zhejiang canc hosp · chinese acad sci

  • K

    Keilholz, Ulrich (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417